Abtin Maghrour

India - the Next R&d Cluster for Biopharmaceuticals? Abtin Maghrour

The? cost? of? discovering? new? drugs? has? increased? significantly,? and? pharmaceutical? Multinational? Corporations? (MNCs)? have? market? pressures? to? decrease? prices? of? drugs. Moreover, the ?patents ?of ?numerous? blockbusters ?will? expire ?within ?the? next? few? years? and? the? MNCs? are? still? not? able? to? replace? them? with? new? profitable? blockbusters. ?Moreover,? companies? from? developing ?countries ?are ?trying? their? best? to? move? up? the? value? chain.? A? country? like? India? has? some? essential? advantages? in? terms? of ?cost ?reduction ?and ?access? to? highly skilled? labour? at ?lower ?cost. ?Therefore? it? is? assumed? that? the? developing? countries? might? have? the? potential? to? become? R&D? clusters.? This? work? will? try? to? identify? some? essential? factors? that? may? indicate? whether? India? has? the? potential? to? become? an? R&D? cluster? for? biopharmaceuticals.??